lungcancersymptomsx.com
Drug: Tagrisso (Osimertinib) to Treat NSCLC
Osimertinib or Tagrisso is an FDA-approved drug by FDA as a frontline treatment for patients with non-small cell lung cancer (NSCLC). It is indicated for the first-line lung cancer treatment of